SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 132 filers reported holding SANA BIOTECHNOLOGY INC in Q4 2023. The put-call ratio across all filers is 8.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $86 | -62.8% | 22,226 | -62.1% | 0.00% | -66.7% |
| Q4 2022 | $231 | -100.0% | 58,569 | -46.1% | 0.00% | -66.7% |
| Q3 2022 | $652,000 | +8.8% | 108,639 | +49.7% | 0.01% | +12.5% |
| Q1 2022 | $599,000 | +47.2% | 72,557 | +175.8% | 0.01% | +100.0% |
| Q4 2021 | $407,000 | – | 26,311 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 25,001,856 | $96,757,183 | 7.02% |
| Omega Fund Management, LLC | 843,750 | $3,265,313 | 3.00% |
| Crestline Management, LP | 3,365,624 | $13,024,965 | 1.52% |
| Trustees of Columbia University in the City of New York | 98,353 | $380,626 | 0.70% |
| Alphabet Inc. | 2,812,500 | $10,884,375 | 0.70% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,963,704 | $11,469,534 | 0.62% |
| Casdin Capital, LLC | 750,000 | $2,902,500 | 0.32% |
| PFM Health Sciences, LP | 1,244,139 | $4,814,818 | 0.23% |
| HARBOURVEST PARTNERS LLC | 137,694 | $532,876 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 540,250 | $2,091 | 0.18% |